Having trouble accessing articles? Reset your cache.

Labour drug pricing plan proposes new rewards for biopharmas beyond profits derived from exclusivity

The U.K.’s Labour Party plan to cut drug prices includes a proposed shake-up in the IP foundations underpinning drug development and commercialization by providing incentives for R&D other than patents.

The

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE